Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Greater than 200 billion annually--

Greater than 200 billion annually--

posted on Oct 25, 2005 02:48PM
The MMP portfolio contains intellectual property that became jointly owned by the privately held TPL Group and publicly held Patriot Scientific in a settlement between them in June 2005. Both TPL and Patriot assert that their jointly owned patents have long been essential to the design of advanced microprocessors, digital signal processors, embedded processors and system-on-chip devices. Global sales of end products deploying chips using technologies protected by the jointly owned patents are estimated to be greater than $200 billion annually. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group enterprise. While major microprocessor manufacturers such as Intel and Advanced Micro Devices were early MMP Portfolio licensees, Alliacense is now focusing its licensing efforts on system manufacturers such as the four defendants cited in the broad-based complaint filed yesterday. For more information on the MMP Portfolio, visit www.alliacense.com.

I sure hope we get news that Sony settled--It is the easiest assuption for me to make. GLTA, ads

Share
New Message
Please login to post a reply